{"disease":{"id":"deficits-neurologic","name":"deficits neurologic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05134116","title":"SafeBoosC III Two-year Follow-up","phase":"","overall_status":"COMPLETED","enrollment_count":1601,"lead_sponsor_name":"Gorm Greisen","has_results":false},{"nct_id":"NCT04170985","title":"NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology","phase":"","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Illumina, Inc.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}